Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

  1. Auner, H.W.
  2. Gavriatopoulou, M.
  3. Delimpasi, S.
  4. Simonova, M.
  5. Spicka, I.
  6. Pour, L.
  7. Dimopoulos, M.A.
  8. Kriachok, I.
  9. Pylypenko, H.
  10. Leleu, X.
  11. Doronin, V.
  12. Usenko, G.
  13. Hajek, R.
  14. Benjamin, R.
  15. Dolai, T.K.
  16. Sinha, D.K.
  17. Venner, C.P.
  18. Garg, M.
  19. Stevens, D.A.
  20. Quach, H.
  21. Jagannath, S.
  22. Moreau, P.
  23. Levy, M.
  24. Badros, A.
  25. Anderson, L.D.
  26. Bahlis, N.J.
  27. Facon, T.
  28. Mateos, M.V.
  29. Cavo, M.
  30. Chai, Y.
  31. Arazy, M.
  32. Shah, J.
  33. Shacham, S.
  34. Kauffman, M.G.
  35. Richardson, P.G.
  36. Grosicki, S.
  37. Erakutsi egile guztiak +
Aldizkaria:
American Journal of Hematology

ISSN: 1096-8652,  0361-8609

Argitalpen urtea: 2021

Alea: 96

Zenbakia: 6

Orrialdeak: 708-718

Mota: Artikulua

DOI: 10.1002/AJH.26172 GOOGLE SCHOLAR lock_openSarbide irekia editor